By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytomX Therapeutics, Inc. 

650 Gateway Boulevard
Suite 125
South San Francisco  California  94080-7014  U.S.A.
Phone: 650-515-4987 Fax: 650-351-0353



Company News
CytomX Therapeutics, Inc. To Present Overview Of Precision Cancer Immunotherapies At The Jefferies Immuno-Oncology Summit 4/13/2015 7:26:56 AM
CytomX Therapeutics, Inc. Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., To Board Of Directors 3/19/2015 6:59:24 AM
CytomX Therapeutics, Inc. Expands Scientific And Clinical Advisory Boards With Leading Experts In Cancer Immunotherapy And Antibody Drug Conjugates 3/2/2015 7:59:39 AM
CytomX Therapeutics, Inc. To Present At Cowen and Company 35th Annual Health Care Conference 2/26/2015 9:52:26 AM
Pfizer (PFE) Leads South San Francisco Biotech CytomX Therapeutics, Inc. to $20 Million Funding Round 1/6/2015 6:25:25 AM
CytomX Therapeutics, Inc. Expands Leadership Team With Addition Of Michael Kavanaugh, M.D., As Chief Scientific Officer And Head Of Research And Early Development 1/5/2015 8:26:05 AM
South San Francisco's CytomX Therapeutics, Inc. Inks Potential $348 Million Cancer-Fighting Deal With Bristol-Myers Squibb Company (BMY) 5/27/2014 6:25:35 AM
CytomX Therapeutics, Inc. To Present Data From Anti-Jagged Probody Program At Upcoming American Association for Cancer Research Annual Meeting 2014 3/26/2014 7:25:39 AM
CytomX Therapeutics, Inc. and ImmunoGen, Inc. (IMGN) Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets 1/9/2014 7:56:38 AM
CytomX Therapeutics, Inc. Presents Data for First-in-Class Jagged Probody™ Program at American Association for Cancer Research-American Association for Cancer Research-EORTC International Conference 10/23/2013 7:02:18 AM